Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition • 09-14 May 2026
|
460-05-001.
MRI-Based Perivascular Space Network Disturbance and Enhanced Coupling in Parkinson’s Disease
Impact: A multi-modal MRI framework enables multi-node detection of the perivascular space network in Parkinson’s disease, revealing network-level disturbance and abnormally strengthened coupling across fluid compartments that predict cognitive decline and offer a quantitative biomarker for individualized cognitive assessment.
|
||
|
460-05-002.
Glymphatic Dysfunction Measured by an Age-Corrected ΔALPS Index is Linked to Motor Symptoms in Early Parkinson's Disease
Impact: By introducing an age-corrected ΔALPS index, this study disentangles Parkinson's disease-specific
glymphatic impairment from normal aging, reveals its specific link to motor
severity, and establishes its potential as an early PD biomarker.
|
||
|
460-05-003.
Diffusion-Cognitive Correlates of Cholinergic Pathways Denervation and Glympathic System Activity in Alzheimer Disease
Impact: Our study establishes diffusion imaging correlates as objective biomarkers for cognitive manifestation by interrogating the relations between cholinergic-NBM (nucleus basalis of Meynert) denervation and glymphatic-related activity, potentially stratifying AD subgroups at risk for personalized management.
|
||
|
460-05-004.
Vascular risk and enlargement of lateral ventricles are associated with DTI-ALPS in Alzheimer's disease
Impact: Multimodal neuroimaging analysis reveals that vascular risks including health of deep medullary vein, burden of white matter hyperintensities, as well as the enlargement of lateral ventricles are associated with DTI-ALPS, suggesting DTI-ALPS to be a vascular and atrophy associated biomarker.
|
||
|
460-05-005.
Multimodal MRI Evaluation of Glymphatic System Function in Patients with Temporal Lobe Epilepsy
Impact: This study’s findings further emphasize the close connection between dysfunctions of the brain's glymphatic system and abnormalities in cerebrospinal fluid dynamics. These discoveries provide important imaging evidence for further investigation into the metabolic clearance mechanisms of TLE and its heterogeneity.
|
||
|
460-05-006.
Glymphatic Impairment: a potential early mechanism in glioma-related epilepsy
Impact: The complexity pathogenesis of glioma‐related epilepsy (GRE) remains incompletely understood, necessitating further investigation into its underlying pathophysiology .
|
||
|
460-05-007.
Distinct Glymphatic Dysfunction Patterns in Glioma and Brain Metastasis Revealed by Diffusion Tensor Imaging–Based ALPS Index
Impact: This study reveals tumor-type–specific patterns
of glymphatic dysfunction and supports DTI-ALPS index as a novel imaging marker
for assessing perivascular clearance failure in neuro-oncology.
|
||
|
460-05-008.
Limited dependence of brain arterial pulsation strength on vascular tone
Impact: Simultaneous measurement of cardiac-cycle induced CSF pulsation strength and BOLD fMRI global signal indicates that pulsation strength is minimally affected by vascular tone. This suggests that previously observed NREM-sleep dependent tissue waste clearance is not explained by increased pulsation strength.
|
||
|
460-05-009.
DTI-ALPS revealed glymphatic system dysfunction in patients with insomnia
Impact: The DTI-ALPS index may serve as a potential imaging biomarker for glymphatic dysfunction in insomnia, aiding in the early identification of patients at risk for cognitive decline.
|
||
|
460-05-010.
Quantitative evaluation of dynamic glymphatic activity in insomnia: A contrast-enhanced synthetic MRI study
Impact: Dynamic contrast-enhanced syMRI enabled quantitative assessment of glymphatic dysfunction in insomnia, providing novel insights into its pathophysiology and potentially facilitating early diagnosis and treatment monitoring of sleep-related neurological disorders.
|
||
|
460-05-011.
How sleep disorder affect glymphatic circulation and network efficiency in internet gaming disorder: Insights from a DTI-ALPS
Impact: This study confirms that sleep disorders exacerbate glymphatic system dysfunction and impair human brain networks in IGD patients.
|
||
|
460-05-012.
7T MRI reveals altered glymphatic function in Cushing’s Disease: a study of enlarged perivascular space
Impact: Using 7T MRI, this study found Cushing's disease patients had a significantly increased number of enlarged perivascular space- (ePVS), suggesting glymphatic system impairment. This non-invasive imaging biomarker may link glymphatic clearance to the neuropsychiatric symptoms of the disease.
|
||
|
460-05-013.
Assessing the Influence of White Matter Microstructure on the Analysis Along the Perivascular Space (ALPS) Index
Impact: Fixel-based ALPS analysis enhances understanding of glymphatic diffusion by disentangling white matter structural effects, providing a more specific neuroimaging marker for detecting glymphatic dysfunction and cognitive decline in neurodegenerative diseases.
|
||
|
460-05-014.
State-dependent alterations of glymphatic function in primary dysmenorrhea: an exploratory, hypothesis-generating study
Impact: This study identifies menstrual-phase–specific hyperactivation of white matter glymphatic function in primary dysmenorrhea (PDM), revealing state-dependent neurofluid regulation linked to age at menarche and emotional factors. These findings suggest potential imaging biomarkers and mechanistic targets for PDM.
|
||
|
460-05-015.
Glymphatic Dysfunction in Type 2 Diabetes: Insights from DTI-ALPS
Impact: Our
findings suggest that DTI-ALPS may help clinicians and researchers better understand
glymphatic dysfunction in T2DM, supporting early identification of cognitive
risk and informing strategies for monitoring brain health in diabetic
populations
|
© 2026 International Society for Magnetic Resonance in Medicine